Welcome to Macroaxis
Sign in to go to your portfolios
Don't have an account? Create It
  Macroaxis: Personalized Investing   The proven technology to invest wisely
Macroaxis Country Selector USA  Change      Macroaxis User Registration Register    Macroaxis User Login Sign In
   
  
 
US Market Closed: May 26, 03:10 AM 2012  
FNMFO KDDIF 096770 AMKBF CTGBZ AU 
 
 
  NYSE  7,534  18.032  Index Moved Down 



Processing
Collecting data for EMIS and GNBT ...

Asset Comparison and Correlation

    
       
Investment horizon: 
30 Days (Login to change)
       
 
    
 Emisphere Technologies Inc.  and   Generex Biotechnology Corp.
Check Correlation Matrix  
Daily Returns (%)
GNBT  EMIS  
Timeline
Assuming 30 trading days horizon, Emisphere Technologies Inc. is expected to under-perform the Generex. In addition to that, Emisphere is 2.07 times more volatile than Generex Biotechnology Corporation. It trades about -0.05 of its total potential returns per unit of risk. Generex Biotechnology Corporation is currently generating about -0.07 per unit of volatility. If you would invest 10.00 in Generex Biotechnology Corporation on April 26, 2012 and sell it today you would earn a total of 0.00 from holding Generex Biotechnology Corporation or generate 0.0% return on investment over 30 days.

Diversification

Weak diversification
Overlapping area represents amount of risk that can be diversified away by holding Emisphere Technologies Inc. and Generex Biotechnology Corp. in the same portfolio (assuming nothing else is changed)

Correlation Coefficient

0.36
 Parameters
Time Period1 Month [change]
DirectionPositive GNBT Moved Up vs EMIS.OB
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns
    
Follow Correlation between EMIS and GNBT with your standard RSS feed, custom widget, or your favorite social app
Add To Reader
 
Add Correlation between EMIS and GNBT to your reader
 
Get social with Correlation between EMIS and GNBT
 Share Correlation between EMIS and GNBT 
Share Share Correlation between EMIS and GNBT
    
    
 
       
Predicted Return Density
Expected Daily Returns   
GNBT  EMIS  

Emisphere Technologies Inc.

 
    
    
Emisphere
Performance
0
Out Of
100
Over 30
Days
Over the last 30 days Emisphere Technologies Inc. has generated negative risk-adjusted returns adding no value to investors with long positions.
    
    
Amgen Inc. vs. Emisphere Technologies Inc.
Gilead Sciences Inc. vs. Emisphere Technologies Inc.
Biogen Idec Inc. vs. Emisphere Technologies Inc.
Celgene Corporation vs. Emisphere Technologies Inc.
Alexion Pharmaceuticals Inc. vs. Emisphere Technologies Inc.
Vertex Pharmaceuticals Incorporated vs. Emisphere Technologies Inc.
  

Generex Biotechnology Corporation

 
    
    
Generex
Performance
0
Out Of
100
Over 30
Days
Over the last 30 days Generex Biotechnology Corporation has generated negative risk-adjusted returns adding no value to investors with long positions.
    
    
PIMCO Total Return B vs. Generex Biotechnology Corporation
PIMCO Total Return D vs. Generex Biotechnology Corporation
PIMCO Total Return Instl vs. Generex Biotechnology Corporation
PIMCO Total Return C vs. Generex Biotechnology Corporation
PIMCO Total Return R vs. Generex Biotechnology Corporation
PIMCO Total Return Admin vs. Generex Biotechnology Corporation
       


 

 
Analytics
Investor Landscape
Efficient Frontier
Market Correlation
Risk and Return Analysis
Financial Content
Portfolio Projections
Portfolio Backtesting
Tools
FAQs
Retirement Optimizer
RSS and Mobile Access
Company Directory
Advisor Directory
Insider Directory
Wealth Management
About Us
About Macroaxis
Contact Us
Terms Of Use
Privacy Policy
Custom Reporting
Product Tour
More ROI Custom Reporting